XBI vs FBT Biotech ETFs Compared | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded19 Aug 2026

Publisherfeeds.acast.com ↗

Handlerec:20064614

Show notes

Biotech investing gets spicy with two ETFs: XBI for broad, high-growth exposure and FBT for focused, stable returns. XBI’s 76% one-year gain outpaces FBT’s 48.8%, but comes with higher risk—beta 1.14 vs. FBT’s 0.66. XBI holds 155 companies (top holdings under 2%), while FBT’s 30 stocks dominate with over 4% each. FBT weathered downturns better, with a 29.9% max drawdown vs. XBI’s 54%. Choose XBI for explosive upside or FBT for steadier sailing—your risk tolerance decides the path. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a6435c5269f8bd36

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.